Safety study of BF844 in healthy volunteers
Part of Brain & nervous system, Ear, nose & throat, Eyes & vision, Genetic & congenital clinical trials.
This study tests a new investigational drug called BF844 in healthy volunteers to see how safe it is and how the body processes it. Participants will take the drug and be monitored closely for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, ages 18 to 45.
- Your weight must be at least 45 kg (99 lbs) and your BMI between 19 and 32.
- You cannot be pregnant, breastfeeding, or trying to conceive during the study.
- You must be willing to stop taking any medications, vitamins, or supplements during the study.
- You cannot have used nicotine (cigarettes, vaping, patches) for at least 28 days before the study.
- You must be willing to avoid caffeine and strenuous exercise during certain parts of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests how a new medication called UI087 moves through your body and whether it's safe. Researchers will compare it to three other drugs given together to understand if combining them into one pill works better.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.
Hear when a new Usher Syndrome Type 3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.